Table 1 Baseline characteristics of patients with normal or low HDL-C.

From: Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment

Variables, n (%)

Normal HDL-C (n = 2102)

Low HDL-C (n = 1629)

p value

Age (yrs)

66.2 ± 11.1

64.7 ± 11.5

 < 0.0001

Gender (Male )

1659 (78.9)

1160 (71.2)

 < 0.0001

BMI (kg/m2)

25.9 ± 3.6

27.0 ± 3.9

 < 0.0001

Cigarette smoking history

963 (45.9)

773 (47.5)

0.33

With anti-platelets therapy

1909 (90.8)

1487 (91.3)

0.66

With ARB/ ACEI

1228 (58.4)

974 (59.8)

0.42

With beta-blocker

1167 (55.5)

1051 (64.5)

 < 0.0001

History of hypertension

1457 (69.7)

1178 (72.3)

0.06

History of heart failure

228 (10.9)

197 (12.1)

0.26

History of diabetes mellitus

633 (34.3)

684 (46.4)

 < 0.0001

Previous coronary/peripheral intervention

1234 (58.7)

1034 (63.5)

0.0034

Coronary artery disease

1955 (93.0)

1555(95.5)

0.0021

Myocardial infarction

1679 (79.9)

1364 (83.7)

0.003

Ischemic stroke/TIA

240 (11.4)

159 (9.8)

0.17

Chronic kidney disease

505 (25.9)

402 (26.9)

0.52

Lipid profile (mg/dL)

Total cholesterol

174.2 ± 39.7

159.2 ± 36.5

 < 0.0001

Triglyceride

118.7 ± 79.9

162 ± 93.0

 < 0.0001

LDL-C

98.2 ± 33.96

92.8 ± 34.2

 < 0.0001

HDL-C

52.6 ± 11.2

34.9 ± 6.8

 < 0.0001

  1. ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TIA transient ischemic attack.